148 related articles for article (PubMed ID: 38142817)
1. Venomous gland transcriptome and venom proteomic analysis of the scorpion Androctonus amoreuxi reveal new peptides with anti-SARS-CoV-2 activity.
Ghazal A; Clarke D; Abdel-Rahman MA; Ribeiro A; Collie-Duguid E; Pattinson C; Burgoyne K; Muhammad T; Alfadhel S; Heidari Z; Samir R; Gerges MM; Nkene I; Colamarino RA; Hijazi K; Houssen WE
Peptides; 2024 Mar; 173():171139. PubMed ID: 38142817
[TBL] [Abstract][Full Text] [Related]
2. Computational screening of 645 antiviral peptides against the receptor-binding domain of the spike protein in SARS-CoV-2.
Sakib MMH; Nishat AA; Islam MT; Raihan Uddin MA; Iqbal MS; Bin Hossen FF; Ahmed MI; Bashir MS; Hossain T; Tohura US; Saif SI; Jui NR; Alam M; Islam MA; Hasan MM; Sufian MA; Ali MA; Islam R; Hossain MA; Halim MA
Comput Biol Med; 2021 Sep; 136():104759. PubMed ID: 34403938
[TBL] [Abstract][Full Text] [Related]
3. Virucidal activity of a scorpion venom peptide variant mucroporin-M1 against measles, SARS-CoV and influenza H5N1 viruses.
Li Q; Zhao Z; Zhou D; Chen Y; Hong W; Cao L; Yang J; Zhang Y; Shi W; Cao Z; Wu Y; Yan H; Li W
Peptides; 2011 Jul; 32(7):1518-25. PubMed ID: 21620914
[TBL] [Abstract][Full Text] [Related]
4. Potential chimeric peptides to block the SARS-CoV-2 spike receptor-binding domain.
Barh D; Tiwari S; Silva Andrade B; Giovanetti M; Almeida Costa E; Kumavath R; Ghosh P; Góes-Neto A; Carlos Junior Alcantara L; Azevedo V
F1000Res; 2020; 9():576. PubMed ID: 32802318
[No Abstract] [Full Text] [Related]
5. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
Nayak SK
Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
[TBL] [Abstract][Full Text] [Related]
6. Examining the interactions scorpion venom peptides (HP1090, Meucin-13, and Meucin-18) with the receptor binding domain of the coronavirus spike protein to design a mutated therapeutic peptide.
Mahnam K; Lotfi M; Shapoorabadi FA
J Mol Graph Model; 2021 Sep; 107():107952. PubMed ID: 34119951
[TBL] [Abstract][Full Text] [Related]
7. Identification and characterization of 7-azaindole derivatives as inhibitors of the SARS-CoV-2 spike-hACE2 protein interaction.
Wang C; He F; Sun K; Guo K; Lu S; Wu T; Gao X; Fang M
Int J Biol Macromol; 2023 Jul; 244():125182. PubMed ID: 37276898
[TBL] [Abstract][Full Text] [Related]
8.
Tiwari V
Biol Open; 2020 Oct; 9(10):. PubMed ID: 32878881
[TBL] [Abstract][Full Text] [Related]
9. Improved Binding Affinity of Omicron's Spike Protein for the Human Angiotensin-Converting Enzyme 2 Receptor Is the Key behind Its Increased Virulence.
Kumar R; Murugan NA; Srivastava V
Int J Mol Sci; 2022 Mar; 23(6):. PubMed ID: 35328828
[TBL] [Abstract][Full Text] [Related]
10. Identification of hACE2-interacting sites in SARS-CoV-2 spike receptor binding domain for antiviral drugs screening.
Hu X; Cui J; Chen J; Du S; Wang X; Zhang Y; Qian J; Chen H; Wei F; Cai Q; Jia J; Wu J
Virus Res; 2022 Nov; 321():198915. PubMed ID: 36084746
[TBL] [Abstract][Full Text] [Related]
11.
Huang X; Pearce R; Zhang Y
Aging (Albany NY); 2020 Jun; 12(12):11263-11276. PubMed ID: 32544884
[TBL] [Abstract][Full Text] [Related]
12. Histidine-rich Modification of a Scorpion-derived Peptide Improves Bioavailability and Inhibitory Activity against HSV-1.
Zeng Z; Zhang R; Hong W; Cheng Y; Wang H; Lang Y; Ji Z; Wu Y; Li W; Xie Y; Cao Z
Theranostics; 2018; 8(1):199-211. PubMed ID: 29290802
[No Abstract] [Full Text] [Related]
13. DNA aptamers inhibit SARS-CoV-2 spike-protein binding to hACE2 by an RBD- independent or dependent approach.
Silwal AP; Thennakoon SKS; Arya SP; Postema RM; Jahan R; Phuoc CMT; Tan X
Theranostics; 2022; 12(12):5522-5536. PubMed ID: 35910791
[No Abstract] [Full Text] [Related]
14. Site Density Functional Theory and Structural Bioinformatics Analysis of the SARS-CoV Spike Protein and hACE2 Complex.
Kumawat N; Tucs A; Bera S; Chuev GN; Valiev M; Fedotova MV; Kruchinin SE; Tsuda K; Sljoka A; Chakraborty A
Molecules; 2022 Jan; 27(3):. PubMed ID: 35164065
[TBL] [Abstract][Full Text] [Related]
15. Rationally Designed ACE2-Derived Peptides Inhibit SARS-CoV-2.
Larue RC; Xing E; Kenney AD; Zhang Y; Tuazon JA; Li J; Yount JS; Li PK; Sharma A
Bioconjug Chem; 2021 Jan; 32(1):215-223. PubMed ID: 33356169
[TBL] [Abstract][Full Text] [Related]
16. Antimicrobial/cytolytic peptides from the venom of the North African scorpion, Androctonus amoreuxi: biochemical and functional characterization of natural peptides and a single site-substituted analog.
Almaaytah A; Zhou M; Wang L; Chen T; Walker B; Shaw C
Peptides; 2012 Jun; 35(2):291-9. PubMed ID: 22484288
[TBL] [Abstract][Full Text] [Related]
17. Targeting SARS-CoV-2 spike protein by stapled hACE2 peptides.
Maas MN; Hintzen JCJ; Löffler PMG; Mecinović J
Chem Commun (Camb); 2021 Apr; 57(26):3283-3286. PubMed ID: 33651072
[TBL] [Abstract][Full Text] [Related]
18. Computational Design and Experimental Validation of ACE2-Derived Peptides as SARS-CoV-2 Receptor Binding Domain Inhibitors.
Sarma S; Herrera SM; Xiao X; Hudalla GA; Hall CK
J Phys Chem B; 2022 Oct; 126(41):8129-8139. PubMed ID: 36219223
[TBL] [Abstract][Full Text] [Related]
19. Venom-gland transcriptomics and venom proteomics of the black-back scorpion (Hadrurus spadix) reveal detectability challenges and an unexplored realm of animal toxin diversity.
Rokyta DR; Ward MJ
Toxicon; 2017 Mar; 128():23-37. PubMed ID: 28115184
[TBL] [Abstract][Full Text] [Related]
20. Identification of an antiviral component from the venom of the scorpion Liocheles australasiae using transcriptomic and mass spectrometric analyses.
Miyashita M; Mitani N; Kitanaka A; Yakio M; Chen M; Nishimoto S; Uchiyama H; Sue M; Hotta H; Nakagawa Y; Miyagawa H
Toxicon; 2021 Feb; 191():25-37. PubMed ID: 33340503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]